- Home
- ALGS
as 07-26-2024 4:00pm EST
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
Upcoming Earnings Alert:
Get ready for potential market movements as Aligos Therapeutics Inc. ALGS prepares to release earnings report on 01 Aug 2024.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 28.8M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 657.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.04 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.35 - $1.20 | Next Earning Date: | 08-01-2024 |
| Revenue: | $13,792,000 | Revenue Growth: | -1.90% |
| Revenue Growth (this year): | -93.5% | Revenue Growth (next year): | N/A |
Latest Aligos Therapeutics Inc. News
ALGS Breaking Stock News: Dive into ALGS Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
Aligos Therapeutics Collaborating With Xiamen Amoytop Biotech in China for Chronic Hepatitis B Patients
GlobeNewswire
4 days ago
Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.
GlobeNewswire
16 days ago
Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB
Zacks
a month ago
AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection
Zacks
a month ago
GSK's Filing for Expanded Use of Jemperli Gets EMA Acceptance
Zacks
a month ago
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks
a month ago
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Zacks
a month ago
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Compare ALGS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALGS Aligos Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.